PROK
PROKIDNEY CORP.
NASDAQ · Healthcare · Biotechnology · US
$1.91
+6.11%Aug 10, 2026, 22:56 UTC
ProKidney Corp. reported a second-quarter loss of $0.15 per share, missing the Zacks Consensus Estimate of a $0.13 loss and matching the year-ago loss of $0.13 per share.
Source: